Results
Oppenheimer Downgrades IBM, Cuts $350 Target
Oppenheimer downgraded IBM to Perform and removed its $350 price target after IBM pre‑announced Q2 2026 results.
IBM reported total revenue of $17.2 billion, a 1% YoY increase, missing consensus estim